AboutSign In

CHORD trial

Event

Regeneron's Phase I/II clinical trial of DB-OTO gene therapy for OTOF-related deafness

1 story

01
health1h ago

Gene Therapy for Inherited Deafness Shows Sustained Hearing Improvement Over 2.5-Year Follow-Up

12 min read